Literature DB >> 8701982

Fas antigen expression and its relationship with apoptosis in human hepatocellular carcinoma and noncancerous tissues.

K Higaki1, H Yano, M Kojiro.   

Abstract

Apoptosis, a programmed cell death, can be observed in the tissues of viral or autoimmune hepatitis and of hepatocellular carcinoma. Fas antigen (Fas) was proposed as a protein that triggers apoptosis. To elucidate the relationship between Fas expression and its location in hepatocellular carcinoma cells, we histochemically examined Fas expression by using 25 hepatocellular carcinoma tissues and their corresponding noncancerous tissues, which were surgically obtained from the same patients. In addition, the relationship between Fas expression and apoptotic cell numbers was examined in the hematoxylin-and-eosin-stained specimens obtained from 23 of the 25 patients. Hepatocellular carcinoma tissues expressed Fas less frequently and more weakly than noncancerous tissues. The majority of noncancerous specimens expressed Fas both on the surface and in the cytoplasm, whereas the majority of hepatocellular carcinoma expressed Fas only in the cytoplasm. Apoptotic cell counts were significantly higher in Fas-expressing tissues than in Fas-negative tissues. Among Fas-expressing tissues, the counts were higher in surface Fas-expressing tissues than in tissues that expressed only cytoplasmic Fas (P < 0.01 to 0.05). Our findings indicate that the development of apoptosis in hepatocellular carcinoma tissues relates to not only Fas expression but also its location.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8701982      PMCID: PMC1865329     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  35 in total

1.  Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity.

Authors:  S Hanabuchi; M Koyanagi; A Kawasaki; N Shinohara; A Matsuzawa; Y Nishimura; Y Kobayashi; S Yonehara; H Yagita; K Okumura
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

2.  Inverse expression of bcl-2 protein and Fas antigen in lymphoblasts in peripheral lymph nodes and activated peripheral blood T and B lymphocytes.

Authors:  T Yoshino; E Kondo; L Cao; K Takahashi; K Hayashi; S Nomura; T Akagi
Journal:  Blood       Date:  1994-04-01       Impact factor: 22.113

3.  Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness.

Authors:  L B Owen-Schaub; R Radinsky; E Kruzel; K Berry; S Yonehara
Journal:  Cancer Res       Date:  1994-03-15       Impact factor: 12.701

4.  Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family.

Authors:  T Suda; T Takahashi; P Golstein; S Nagata
Journal:  Cell       Date:  1993-12-17       Impact factor: 41.582

Review 5.  Apoptosis. Its significance in cancer and cancer therapy.

Authors:  J F Kerr; C M Winterford; B V Harmon
Journal:  Cancer       Date:  1994-04-15       Impact factor: 6.860

6.  Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.

Authors:  T Takahashi; M Tanaka; C I Brannan; N A Jenkins; N G Copeland; T Suda; S Nagata
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

7.  Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C.

Authors:  N Hiramatsu; N Hayashi; K Katayama; K Mochizuki; Y Kawanishi; A Kasahara; H Fusamoto; T Kamada
Journal:  Hepatology       Date:  1994-06       Impact factor: 17.425

8.  Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule.

Authors:  J Cheng; T Zhou; C Liu; J P Shapiro; M J Brauer; M C Kiefer; P J Barr; J D Mountz
Journal:  Science       Date:  1994-03-25       Impact factor: 47.728

9.  The apoptosis-1/Fas protein in human systemic lupus erythematosus.

Authors:  E Mysler; P Bini; J Drappa; P Ramos; S M Friedman; P H Krammer; K B Elkon
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

10.  Purification and characterization of the Fas-ligand that induces apoptosis.

Authors:  T Suda; S Nagata
Journal:  J Exp Med       Date:  1994-03-01       Impact factor: 14.307

View more
  17 in total

1.  The effects of cell density, attachment substratum and dexamethasone on spontaneous apoptosis of rat hepatocytes in primary culture.

Authors:  L Qiao; G C Farrell
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999 Jul-Aug       Impact factor: 2.416

2.  Clinical significance of Fas antigen expression in gastric carcinoma.

Authors:  Hai-Feng Liu; Wei-Wen Liu; Dian-Chun Fang; Feng-Xian Liu; Guang-You He
Journal:  World J Gastroenterol       Date:  1999-02       Impact factor: 5.742

Review 3.  Hepatocyte death: a clear and present danger.

Authors:  Harmeet Malhi; Maria Eugenia Guicciardi; Gregory J Gores
Journal:  Physiol Rev       Date:  2010-07       Impact factor: 37.312

Review 4.  Apoptosis: a mechanism of acute and chronic liver injury.

Authors:  M E Guicciardi; G J Gores
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

Review 5.  Bridging the molecular and biological functions of the oxysterol-binding protein family.

Authors:  Antonietta Pietrangelo; Neale D Ridgway
Journal:  Cell Mol Life Sci       Date:  2018-03-13       Impact factor: 9.261

6.  The expression and regulation of DFNA5 in human hepatocellular carcinoma DFNA5 in hepatocellular carcinoma.

Authors:  Cong-Jun Wang; Lin Tang; Dong-Wei Shen; Chao Wang; Qiong-Ying Yuan; Wei Gao; Yong-Kun Wang; Rong-Hua Xu; Hui Zhang
Journal:  Mol Biol Rep       Date:  2013-10-24       Impact factor: 2.316

7.  Hepatitis B Virus Surface Antigen Enhances the Sensitivity of Hepatocytes to Fas-Mediated Apoptosis via Suppression of AKT Phosphorylation.

Authors:  Zhen-Tang Jing; Wei Liu; Shu-Xiang Wu; Yun He; Yan-Ting Lin; Wan-Nan Chen; Xin-Jian Lin; Xu Lin
Journal:  J Immunol       Date:  2018-08-31       Impact factor: 5.422

8.  Oxysterol-binding protein-related protein 8 (ORP8) increases sensitivity of hepatocellular carcinoma cells to Fas-mediated apoptosis.

Authors:  Wenbin Zhong; Shengying Qin; Biying Zhu; Miaoshui Pu; Fupei Liu; Lin Wang; Guilin Ye; Qing Yi; Daoguang Yan
Journal:  J Biol Chem       Date:  2015-01-16       Impact factor: 5.157

9.  Antitumoral gene-based strategy involving nitric oxide synthase type III overexpression in hepatocellular carcinoma.

Authors:  Á J De la Rosa; Á Rodríguez-Hernández; R González; S Romero-Brufau; E Navarro-Villarán; L Barrera-Pulido; S Pereira; L M Marín; F López-Bernal; J M Álamo; M A Gómez-Bravo; F J Padillo; J Muntané
Journal:  Gene Ther       Date:  2015-07-23       Impact factor: 5.250

10.  Inhibition of casein kinase 2 enhances the death ligand- and natural kiler cell-induced hepatocellular carcinoma cell death.

Authors:  H-R Kim; K Kim; K-H Lee; S J Kim; J Kim
Journal:  Clin Exp Immunol       Date:  2008-03-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.